CAI Stock Summary and Trading Ideas (Caris Life Sciences | NASDAQ:CAI)

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Caris Life Sciences trades on the NASDAQ stock market under the symbol CAI.

As of July 24, 2026, CAI stock price declined to $15.52 with 4,716,536 million shares trading.

CAI has a beta of 1.86, meaning it tends to be more sensitive to market movements. CAI has a correlation of 0.17 to the broad based SPY ETF.

CAI has a market cap of $4.39 billion. This is considered a Mid Cap stock.

Last quarter Caris Life Sciences reported $216 million in Revenue and $.00 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.02.

The top ETF exchange traded funds that CAI belongs to (by Net Assets): VTI, VB, VBK, IBB, IWP.

CAI has underperformed the market in the last year with a price return of -47.4% while the SPY ETF gained +17.7%. CAI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.2% and -8.7%, respectively, while the SPY returned +3.8% and -2.1%, respectively.

CAI support price is $14.98 and resistance is $16.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAI shares will trade within this expected range on the day.